In contrast, hepatoma cells treated with the same conditions showed intense fluorescence characteristics, which indicated that niosomes modified with galactosylated stearate had better targeting ability to hepatoma cells, and did not easily target A2780 and HCT8 cells without ASGPR expression (Fig. 2). This evidence concerns the gene ASGR1 and hepatocellular carcinoma.